patent/WO-03060094-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03060094-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfa2eb8416516734fec04f99dceffe84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978b0e2d862e6646bb11e52d395c5c3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b0319bf107133bbbb359f22e55e71b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbbd6430b22b3c5b203b09af81501ae8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_599d47f8d276ee96c0eb005775178461 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-18
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
filingDate	2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da134c1ec817078f20083c6828600ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d9920494dc1bdef70765b56a6f86fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be470bba452f1202a74c529a4cdb284f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a952187a07ca5b1071361f8e56b9789e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ce47de7e6621053122c66a85769a67
publicationDate	2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-03060094-A3
titleOfInvention	Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers
abstract	Provided is a method of selectively enzymatically esterifying or selectively enzymatically solvolyzing epimers of analogs of vitamin D having a stereogenic center at C-24 that has a free or esterified OH group. The method can be used, for example, for separating mixed epimers of the vitamin D analog.
priorityDate	2002-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665716-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 28.